Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis
- 1 March 2007
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 7 (3), 333-342
- https://doi.org/10.1016/j.intimp.2006.11.006
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis modelBritish Journal of Pharmacology, 2006
- Cyclooxygenase-2 expression and oxidative DNA adducts in murine intestinal adenomas: Modification by dietary curcumin and implications for clinical trialsEuropean Journal Of Cancer, 2006
- Mitogen‐activated protein kinase and activator protein‐1 dependent signals are essential for Bacteroides fragilis enterotoxin‐induced enteritisEuropean Journal of Immunology, 2005
- Expression of NOX1, a superoxide‐generating NADPH oxidase, in colon cancer and inflammatory bowel diseaseThe Journal of Pathology, 2005
- Protective effects of curcumin against amiodarone‐induced pulmonary fibrosis in ratsBritish Journal of Pharmacology, 2003
- Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid‐induced colitisBritish Journal of Pharmacology, 2003
- Estimation of Mucosal Inflammatory Mediators in Rat DSS-Induced ColitisDigestion, 2001
- TRAF2 Is Essential for JNK but Not NF-κB Activation and Regulates Lymphocyte Proliferation and SurvivalImmunity, 1997
- Lactoferrin: Molecular Structure and Biological FunctionAnnual Review of Nutrition, 1995
- Pharmacology ofCurcuma longaPlanta Medica, 1991